
Heidi L. Reese
Examiner (ID: 18337, Phone: (571)270-5277 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1622, 1657, 1625 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14072117
[patent_doc_number] => 20190084946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS USING HDAC11 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/202210
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202210 | Methods using HDAC11 inhibitors | Nov 27, 2018 | Issued |
Array
(
[id] => 14372407
[patent_doc_number] => 20190160116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => DERMATOLOGIC COMPOSITION CONTAINING ESCHERICHIA COLI AND ENTEROCOCCUS FAECALIS
[patent_app_type] => utility
[patent_app_number] => 16/202409
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202409
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202409 | Dermatologic composition containing | Nov 27, 2018 | Issued |
Array
(
[id] => 14072115
[patent_doc_number] => 20190084945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS USING HDAC11 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/202207
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 442
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202207 | Methods using HDAC11 inhibitors | Nov 27, 2018 | Issued |
Array
(
[id] => 14342103
[patent_doc_number] => 20190153024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => NOVEL SALTS AND POLYMORPHS OF SCY-078
[patent_app_type] => utility
[patent_app_number] => 16/203273
[patent_app_country] => US
[patent_app_date] => 2018-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26253
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16203273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/203273 | Salts and polymorphs of SCY-078 | Nov 27, 2018 | Issued |
Array
(
[id] => 14098939
[patent_doc_number] => 20190091145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => Probiotic Tablet Formulations
[patent_app_type] => utility
[patent_app_number] => 16/201422
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16201422
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/201422 | Probiotic Tablet Formulations | Nov 26, 2018 | Abandoned |
Array
(
[id] => 15193781
[patent_doc_number] => 10494369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Histone demethylase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/202072
[patent_app_country] => US
[patent_app_date] => 2018-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29470
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16202072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/202072 | Histone demethylase inhibitors | Nov 26, 2018 | Issued |
Array
(
[id] => 17421211
[patent_doc_number] => 11254652
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide
[patent_app_type] => utility
[patent_app_number] => 16/765456
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 27
[patent_no_of_words] => 28237
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16765456
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/765456 | Crystalline forms of N-(4-(4-(cyclopropymethyl)piperazine-1-carbonyl)phenyl)quinoline-8-sulfonamide | Nov 20, 2018 | Issued |
Array
(
[id] => 14276991
[patent_doc_number] => 20190135780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/195550
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 155681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195550
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195550 | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same | Nov 18, 2018 | Issued |
Array
(
[id] => 16297702
[patent_doc_number] => 20200283425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => PYRIMIDINE SULFAMIDE DERIVATIVE AND PREPARATION METHOD AND MEDICAL APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/764654
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764654
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764654 | Pyrimidine sulfamide derivative and preparation method and medical application thereof | Nov 18, 2018 | Issued |
Array
(
[id] => 15631875
[patent_doc_number] => 10588905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Compositions and methods for treatment of fragile X syndrome
[patent_app_type] => utility
[patent_app_number] => 16/194625
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 8321
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194625
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194625 | Compositions and methods for treatment of fragile X syndrome | Nov 18, 2018 | Issued |
Array
(
[id] => 14072173
[patent_doc_number] => 20190084974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => PYRAZOLE COMPOUNDS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/195794
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16195794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/195794 | Pyrazole compounds and methods of use thereof | Nov 18, 2018 | Issued |
Array
(
[id] => 14534321
[patent_doc_number] => 20190202782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
[patent_app_type] => utility
[patent_app_number] => 16/186275
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16186275
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/186275 | Compounds and uses thereof for the modulation of hemoglobin | Nov 8, 2018 | Issued |
Array
(
[id] => 14040647
[patent_doc_number] => 20190076430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-14
[patent_title] => OUTPATIENT MODIFIED RAPID DETOXIFICATION FOR ADDICTION TO ALCOHOL AND DRUGS
[patent_app_type] => utility
[patent_app_number] => 16/185953
[patent_app_country] => US
[patent_app_date] => 2018-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16185953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/185953 | Outpatient modified rapid detoxification for addiction to alcohol and drugs | Nov 8, 2018 | Issued |
Array
(
[id] => 17513655
[patent_doc_number] => 11292784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate
[patent_app_type] => utility
[patent_app_number] => 16/764432
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 38001
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16764432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/764432 | Crystalline forms of ethyl 2-[[3-[[3- chloro-5-fluoro-6-[3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]-2-pyridyl]oxy] acetate | Nov 7, 2018 | Issued |
Array
(
[id] => 17905472
[patent_doc_number] => 11459315
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Modulators of methyl modifying enzymes, compositions and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/762600
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43006
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16762600
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/762600 | Modulators of methyl modifying enzymes, compositions and uses thereof | Nov 7, 2018 | Issued |
Array
(
[id] => 14310413
[patent_doc_number] => 20190144910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => PRODUCT DEMONSTRATION DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/184587
[patent_app_country] => US
[patent_app_date] => 2018-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16184587
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/184587 | PRODUCT DEMONSTRATION DEVICE | Nov 7, 2018 | Abandoned |
Array
(
[id] => 17089980
[patent_doc_number] => 11118160
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Probiotic composition for enhancing an insects resistance to a pesticide
[patent_app_type] => utility
[patent_app_number] => 16/183529
[patent_app_country] => US
[patent_app_date] => 2018-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 6011
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16183529
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/183529 | Probiotic composition for enhancing an insects resistance to a pesticide | Nov 6, 2018 | Issued |
Array
(
[id] => 17634982
[patent_doc_number] => 11345694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Antibacterial compounds
[patent_app_type] => utility
[patent_app_number] => 16/761016
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41234
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 387
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/761016 | Antibacterial compounds | Nov 1, 2018 | Issued |
Array
(
[id] => 14810179
[patent_doc_number] => 20190271699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHODS AND COMPOSITIONS FOR THE DETECTION OF MICROBIAL CONTAMINANTS
[patent_app_type] => utility
[patent_app_number] => 16/178856
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178856 | METHODS AND COMPOSITIONS FOR THE DETECTION OF MICROBIAL CONTAMINANTS | Nov 1, 2018 | Abandoned |
Array
(
[id] => 16893414
[patent_doc_number] => 11034950
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Delivering enzyme using an injectable hydrogel depot
[patent_app_type] => utility
[patent_app_number] => 16/179158
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5405
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179158
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179158 | Delivering enzyme using an injectable hydrogel depot | Nov 1, 2018 | Issued |